280 related articles for article (PubMed ID: 28560708)
1. Tonabersat Prevents Inflammatory Damage in the Central Nervous System by Blocking Connexin43 Hemichannels.
Kim Y; Griffin JM; Nor MNM; Zhang J; Freestone PS; Danesh-Meyer HV; Rupenthal ID; Acosta M; Nicholson LFB; O'Carroll SJ; Green CR
Neurotherapeutics; 2017 Oct; 14(4):1148-1165. PubMed ID: 28560708
[TBL] [Abstract][Full Text] [Related]
2. Connexin Hemichannel Block Using Orally Delivered Tonabersat Improves Outcomes in Animal Models of Retinal Disease.
Mat Nor MN; Rupenthal ID; Green CR; Acosta ML
Neurotherapeutics; 2020 Jan; 17(1):371-387. PubMed ID: 31637594
[TBL] [Abstract][Full Text] [Related]
3. Differential Action of Connexin Hemichannel and Pannexin Channel Therapeutics for Potential Treatment of Retinal Diseases.
Mat Nor MN; Rupenthal ID; Green CR; Acosta ML
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33578721
[TBL] [Abstract][Full Text] [Related]
4. Characterizing the mode of action of extracellular Connexin43 channel blocking mimetic peptides in an in vitro ischemia injury model.
Kim Y; Griffin JM; Harris PW; Chan SH; Nicholson LF; Brimble MA; O'Carroll SJ; Green CR
Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):68-78. PubMed ID: 27816754
[TBL] [Abstract][Full Text] [Related]
5. Tonabersat Inhibits Connexin43 Hemichannel Opening and Inflammasome Activation in an In Vitro Retinal Epithelial Cell Model of Diabetic Retinopathy.
Lyon H; Shome A; Rupenthal ID; Green CR; Mugisho OO
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396676
[TBL] [Abstract][Full Text] [Related]
6. Connexin43 mimetic peptide reduces vascular leak and retinal ganglion cell death following retinal ischaemia.
Danesh-Meyer HV; Kerr NM; Zhang J; Eady EK; O'Carroll SJ; Nicholson LF; Johnson CS; Green CR
Brain; 2012 Feb; 135(Pt 2):506-20. PubMed ID: 22345088
[TBL] [Abstract][Full Text] [Related]
7. Connexin43 hemichannel block inhibits NLRP3 inflammasome activation in a human retinal explant model of diabetic retinopathy.
Louie HH; Shome A; Kuo CY; Rupenthal ID; Green CR; Mugisho OO
Exp Eye Res; 2021 Jan; 202():108384. PubMed ID: 33285185
[TBL] [Abstract][Full Text] [Related]
8. Orally Delivered Connexin43 Hemichannel Blocker, Tonabersat, Inhibits Vascular Breakdown and Inflammasome Activation in a Mouse Model of Diabetic Retinopathy.
Mugisho OO; Aryal J; Shome A; Lyon H; Acosta ML; Green CR; Rupenthal ID
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835288
[TBL] [Abstract][Full Text] [Related]
9. Connexin hemichannel inhibition reduces acetaminophen-induced liver injury in mice.
Maes M; Crespo Yanguas S; Willebrords J; Weemhoff JL; da Silva TC; Decrock E; Lebofsky M; Pereira IVA; Leybaert L; Farhood A; Jaeschke H; Cogliati B; Vinken M
Toxicol Lett; 2017 Aug; 278():30-37. PubMed ID: 28687253
[TBL] [Abstract][Full Text] [Related]
10. Connexin43 Mimetic Peptide Improves Retinal Function and Reduces Inflammation in a Light-Damaged Albino Rat Model.
Guo CX; Mat Nor MN; Danesh-Meyer HV; Vessey KA; Fletcher EL; O'Carroll SJ; Acosta ML; Green CR
Invest Ophthalmol Vis Sci; 2016 Aug; 57(10):3961-73. PubMed ID: 27490318
[TBL] [Abstract][Full Text] [Related]
11. Connexin43 hemichannel block protects against retinal pigment epithelial cell barrier breakdown.
Kuo C; Green CR; Rupenthal ID; Mugisho OO
Acta Diabetol; 2020 Jan; 57(1):13-22. PubMed ID: 31030263
[TBL] [Abstract][Full Text] [Related]
12. Tonabersat inhibits trigeminal ganglion neuronal-satellite glial cell signaling.
Damodaram S; Thalakoti S; Freeman SE; Garrett FG; Durham PL
Headache; 2009 Jan; 49(1):5-20. PubMed ID: 19125874
[TBL] [Abstract][Full Text] [Related]
13. At the cross-point of connexins, calcium, and ATP: blocking hemichannels inhibits vasoconstriction of rat small mesenteric arteries.
Bol M; Wang N; De Bock M; Wacquier B; Decrock E; Gadicherla A; Decaluwé K; Vanheel B; van Rijen HV; Krysko DV; Bultynck G; Dupont G; Van de Voorde J; Leybaert L
Cardiovasc Res; 2017 Feb; 113(2):195-206. PubMed ID: 27677282
[TBL] [Abstract][Full Text] [Related]
14. Targeting connexin hemichannels to control the inflammasome: the correlation between connexin43 and NLRP3 expression in chronic eye disease.
Mugisho OO; Rupenthal ID; Paquet-Durand F; Acosta ML; Green CR
Expert Opin Ther Targets; 2019 Oct; 23(10):855-863. PubMed ID: 31554417
[No Abstract] [Full Text] [Related]
15. ATP and glutamate released via astroglial connexin 43 hemichannels mediate neuronal death through activation of pannexin 1 hemichannels.
Orellana JA; Froger N; Ezan P; Jiang JX; Bennett MV; Naus CC; Giaume C; Sáez JC
J Neurochem; 2011 Sep; 118(5):826-40. PubMed ID: 21294731
[TBL] [Abstract][Full Text] [Related]
16. The inflammasome pathway is amplified and perpetuated in an autocrine manner through connexin43 hemichannel mediated ATP release.
Mugisho OO; Green CR; Kho DT; Zhang J; Graham ES; Acosta ML; Rupenthal ID
Biochim Biophys Acta Gen Subj; 2018 Mar; 1862(3):385-393. PubMed ID: 29158134
[TBL] [Abstract][Full Text] [Related]
17. Ultrafine carbon black induces glutamate and ATP release by activating connexin and pannexin hemichannels in cultured astrocytes.
Wei H; Deng F; Chen Y; Qin Y; Hao Y; Guo X
Toxicology; 2014 Sep; 323():32-41. PubMed ID: 24932759
[TBL] [Abstract][Full Text] [Related]
18. Connexin and pannexin hemichannels in inflammatory responses of glia and neurons.
Bennett MV; Garré JM; Orellana JA; Bukauskas FF; Nedergaard M; Sáez JC
Brain Res; 2012 Dec; 1487():3-15. PubMed ID: 22975435
[TBL] [Abstract][Full Text] [Related]
19. Ischemia induces closure of gap junctional channels and opening of hemichannels in heart-derived cells and tissue.
Johansen D; Cruciani V; Sundset R; Ytrehus K; Mikalsen SO
Cell Physiol Biochem; 2011; 28(1):103-14. PubMed ID: 21865853
[TBL] [Abstract][Full Text] [Related]
20. Blocking connexin 43 hemichannel-mediated ATP release reduces communication within and between tubular epithelial cells and medullary fibroblasts in a model of diabetic nephropathy.
Williams BM; Cliff CL; Demirel I; Squires PE; Hills CE
Diabet Med; 2022 Dec; 39(12):e14963. PubMed ID: 36256487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
